Hypoactive Sexual Desire Disorder

addyi-femaleviagra_ap_2

This website has been poking fun at the nonsense in our healthcare system for 14 years.  Why?  Because no one else will.  Here is an example. Flibanserin (Addyi) is labeled for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women and it’s a medication that affects serotonin receptors to increase libido. Here is the fun part. Women with HSDD reported an increase of 1.6 to 2.5 additional satisfying sexual events per month with this drug versus .8 to 1.5 additional events with  placebo.  And this was cleared by the FDA!  Yes, you read that right.  Flibanserin at a cost of $830 per month (100 mg per day) gives the patient one more satisfying event.  I hope this is making your mind spin with ideas because it did mine.  What else would a 46-year-old premenopausal women do for that $830 to attain that extra event?  The husband could buy her jewelry, spa dates, have the house cleaned, give her a massage, take her to a weekend at a beautiful resort, etc.  Or, the women could pay for a high end escort at $500 for a night with the husband and have an extra $300 to play around with.  I am just spitballing here but you get my point.  I am sure you have some other ideas so please put them in the comment section for others to see.

87020cookie-checkHypoactive Sexual Desire Disorder